I 116TH CONGRESS 1ST SESSION H. R. 3927 To direct the Secretary of Health and Human Services to carry out a pilot program to test the feasibility and outcomes of integrating a sub- stance use disorder and behavioral health treatment locator tool into the prescription drug monitoring programs of 5 eligible States. IN THE HOUSE OF REPRESENTATIVES JULY 24, 2019 Mr. MCKINLEY (for himself and Ms. BLUNT ROCHESTER) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To direct the Secretary of Health and Human Services to carry out a pilot program to test the feasibility and outcomes of integrating a substance use disorder and behavioral health treatment locator tool into the prescrip- tion drug monitoring programs of 5 eligible States. Be it enacted by the Senate and House of Representa- 1 tives of the United States of America in Congress assembled, 2 SECTION 1. SHORT TITLE. 3 This Act may be cited as the ‘‘PDMPs Help Patients 4 Act of 2019’’. 5 VerDate Sep 11 2014 18:31 Aug 03, 2019 Jkt 034408 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H3927.IH H3927 Pbinns on DSK79D2C42PROD with BILLS 2 •HR 3927 IH SEC. 2. PILOT PROGRAM FOR INTEGRATING SUBSTANCE 1 USE DISORDER AND BEHAVIORAL HEALTH 2 TREATMENT LOCATOR TOOL INTO STATE 3 PRESCRIPTION DRUG MONITORING PRO- 4 GRAMS. 5 (a) IN GENERAL.—The Secretary of Health and 6 Human Services, in consultation with the Assistant Sec- 7 retary for Mental Health and Substance Use, shall estab- 8 lish and implement a pilot program in which the Secretary 9 awards grants to, or enters into cooperative agreements 10 with, not more than 5 eligible States to test the feasibility 11 and outcomes of integrating a substance use disorder and 12 behavioral health treatment locator tool into the State’s 13 prescription drug monitoring program. 14 (b) GRANT ESTABLISHMENT AND PARTICIPATION.— 15 (1) IN GENERAL.—In carrying out the pilot 16 program under this section, the Secretary shall, on 17 a competitive basis, award grants to, or enter into 18 cooperative agreements with, not more than 5 eligi- 19 ble States. 20 (2) ELIGIBILITY.—To be eligible for a grant 21 under this section, a State shall demonstrate to the 22 Secretary’s satisfaction that the State is making 23 progress in integrating the State’s PDMP with elec- 24 tronic health records and health information tech- 25 nology infrastructure. 26 VerDate Sep 11 2014 18:31 Aug 03, 2019 Jkt 034408 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H3927.IH H3927 Pbinns on DSK79D2C42PROD with BILLS 3 •HR 3927 IH (3) PREFERENCE.—In awarding grants under 1 this section, the Secretary shall give preference to el- 2 igible States described in paragraph (2) whose rates 3 of death due to drug overdose per population of 4 100,000 are in the top quartile according to the 5 most recent data of the Centers for Disease Control 6 and Prevention. 7 (c) PERIOD OF GRANT.—A grant awarded to an eligi- 8 ble entity under this section shall be for a period of 2 9 years. 10 (d) GRANT USES.— 11 (1) REQUIRED USES.—A grant awarded under 12 this section to an eligible State shall be used for 13 both of the following purposes: 14 (A) To integrate a substance use disorder 15 and behavioral health treatment locator tool 16 into the PDMP. 17 (B) To develop and disseminate guidance 18 for health care providers on how to consult and 19 share information obtained through the sub- 20 stance use disorder and behavioral health treat- 21 ment locator tool when a patient’s PDMP infor- 22 mation indicates possible misuse of a controlled 23 substance. 24 VerDate Sep 11 2014 18:31 Aug 03, 2019 Jkt 034408 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H3927.IH H3927 Pbinns on DSK79D2C42PROD with BILLS 4 •HR 3927 IH (2) ADDITIONAL PERMISSIBLE USES.—A grant 1 awarded under this section to an eligible State may 2 be used for any of the following additional purposes: 3 (A) To integrate a substance use disorder 4 and behavioral health treatment locator tool 5 into the PDMP that incorporates direct referral 6 capabilities that enable the health care pro- 7 vider— 8 (i) to refer a patient to treatment or 9 for an assessment; and 10 (ii) consistent with the protection of 11 information by Federal and State privacy 12 laws and privacy and security rules, receive 13 feedback about the patient’s engagement 14 with such treatment or assessment. 15 (B) To integrate a substance use disorder 16 and behavioral health treatment locator tool 17 into the PDMP that provides information re- 18 garding the current capacity of inpatient or 19 outpatient treatment resources of a health care 20 provider. 21 (e) REPORTING REQUIREMENTS.— 22 (1) REPORTS BY STATES.—Each eligible State 23 that participates in the pilot program under this sec- 24 tion shall submit to the Secretary an annual report 25 VerDate Sep 11 2014 18:31 Aug 03, 2019 Jkt 034408 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\H3927.IH H3927 Pbinns on DSK79D2C42PROD with BILLS 5 •HR 3927 IH for each year of the pilot program that includes in- 1 formation on— 2 (A) the number of health care providers 3 and health facilities with access to the sub- 4 stance use disorder and behavioral health treat- 5 ment locator tool; 6 (B) the number of individuals referred to 7 treatment with the assistance of the locator 8 tool; 9 (C) aggregate, de-identified patient data 10 related to the type of treatment located by the 11 locator tool, how often patients followed 12 through on seeking such treatment, and the av- 13 erage duration of such treatment, to the extent 14 collected by the State; 15 (D) feedback from providers with access to 16 the locator tool on usability and any impact on 17 outcomes; 18 (E) recommendations to improve the 19 usability and efficacy of a substance use dis- 20 order and behavioral health treatment locator 21 tool within the PDMP; and 22 (F) additional information and reporting 23 metrics as determined by the Secretary. 24 VerDate Sep 11 2014 18:31 Aug 03, 2019 Jkt 034408 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\H3927.IH H3927 Pbinns on DSK79D2C42PROD with BILLS 6 •HR 3927 IH (2) REPORT BY SECRETARY.—Not less than 1 180 days after the conclusion of the pilot program 2 under this section, the Secretary shall submit to the 3 Congress a report on the findings of the program, 4 including— 5 (A) outcomes reported by the participating 6 States; 7 (B) findings on the suitability of including 8 a substance use disorder and behavioral health 9 treatment locator tool within State PDMPs; 10 and 11 (C) recommendations on best practices for 12 integrating a substance use disorder and behav- 13 ioral health treatment locator tool within State 14 PDMPs. 15 (f) DEFINITIONS.—In this section: 16 (1) The term ‘‘prescription drug monitoring 17 program’’ or ‘‘PDMP’’ has the meaning given to the 18 term ‘‘PDMP’’ in section 399O of the Public Health 19 Service Act (42 U.S.C. 280g–3). 20 (2) The term ‘‘Secretary’’ means the Secretary 21 of Health and Human Services. 22 VerDate Sep 11 2014 21:27 Aug 09, 2019 Jkt 089200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6201 E:\BILLS\H3927.IH H3927 Pbinns on DSK79D2C42PROD with BILLS 7 •HR 3927 IH (g) AUTHORIZATION OF APPROPRIATIONS.—To carry 1 out this section, there are authorized to be appropriated 2 $2,500,000 for each of fiscal years 2020 and 2021. 3 Æ VerDate Sep 11 2014 21:27 Aug 09, 2019 Jkt 089200 PO 00000 Frm 00007 Fmt 6652 Sfmt 6301 E:\BILLS\H3927.IH H3927 Pbinns on DSK79D2C42PROD with BILLS